Acta Scientific Clinical Case Reports (ASCR)

Short Communication Volume 6 Issue 9

The Specifics of Sleep Disorders in Women with Breast Cancer

Melehin AI*

PhD, Associate Professor, Professor of the Russian Academy of Natural Sciences, Honorary Doctor of Science (Doctor of Science, Honoris Causa), Clinical Psychologist of the Highest Qualification Category, Moscow, Russia

*Corresponding Author: Melehin AI, PhD, Associate Professor, Professor of the Russian Academy of Natural Sciences, Honorary Doctor of Science (Doctor of Science, Honoris Causa), Clinical Psychologist of the Highest Qualification Category, Moscow, Russia.

Received: August 06, 2025; Published: August 29, 2025

Abstract

The prognostic role of sleep disorders in oncological disorders is still underestimated worldwide. The prevalence of insomnia is highest in breast cancer (42-69%) compared with other localizations (for example, prostate, gynecological diseases, head and neck, urinary tract or gastrointestinal tract, etc

References

  1. Melehin AI. “Psychoanalytic psychosomatics and psychoncology”. Introductory guide. Galaktika Publishing House, Moscow (2025): 320.
  2. Melehin AI. “Clinical psychology of chronic insomnia”. DMK Press, Moscow, 370 (2024).
  3. Duran-Gomez N., et al. “The need for a comprehensive assessment of sleep disorders and management of patients with breast cancer”. Scientific Report 15 (2025): 21235.
  4. Joshua F Wiley., et al. “Randomized controlled trial of cognitive behavioral therapy and bright light therapy for insomnia and overwork during breast cancer treatment: SleepCaRe trial”. JCO 43 (2025): 12009-1200.
  5. Lemelin A., et al. “Association of insomnia with febrile neutropenia, leukopenia, and infection in women receiving adjuvant chemotherapy for breast cancer”. Cancers 17 (2025): 1838.

Citation

Citation: Melehin AI. “The Specifics of Sleep Disorders in Women with Breast Cancer". Acta Scientific Clinical Case Reports 6.9 (2025): 19-20.

Copyright

Copyright: © 2025 Melehin AI. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In